Imclone systems (IMCL) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL)

IMCL 0.159

0.0%

Oct 5 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cacaito who wrote (2172)	3/6/2002 7:41:23 AM
From: IRWIN JAMES FRANKEL	Read Replies (2) of 2515

Cacaito, I thought there was a deal to be done. Now we see it. The parties will work the drug not the courts. BMY is being paid for the larger role in the approval process by a $100 million reduction in the 2nd milestone. The change in timing of the 3rd milestone reflects reduced value of the deal due to the delay. I do not understand your statement, "The "flat based" 39% on revnues "distribution fee" decreases the future profits of Imcl 50% or more, if Bmy goes tough it could be a bigger reduction." Maybe someone can explain this to me. ij PS - Lawyers are great when you NEED them, much like doctors. <g>

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next